ZA879663B - Propiophenone derivatives for treatmento of pollakiuria(frequency urination) - Google Patents

Propiophenone derivatives for treatmento of pollakiuria(frequency urination)

Info

Publication number
ZA879663B
ZA879663B ZA879663A ZA879663A ZA879663B ZA 879663 B ZA879663 B ZA 879663B ZA 879663 A ZA879663 A ZA 879663A ZA 879663 A ZA879663 A ZA 879663A ZA 879663 B ZA879663 B ZA 879663B
Authority
ZA
South Africa
Prior art keywords
treatmento
pollakiuria
straight
propiophenone derivatives
represents hydrogen
Prior art date
Application number
ZA879663A
Other languages
English (en)
Inventor
Itoh Yasuo
Kato Hideo
Koshinaka Eiichi
Morikawa Kouji
Yamauchi Toshie
Original Assignee
Hokuriku Pharmaceutical Co.,Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17984801&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA879663(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hokuriku Pharmaceutical Co.,Ltd. filed Critical Hokuriku Pharmaceutical Co.,Ltd.
Publication of ZA879663B publication Critical patent/ZA879663B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA879663A 1986-12-26 1987-12-23 Propiophenone derivatives for treatmento of pollakiuria(frequency urination) ZA879663B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61308747A JPH0637389B2 (ja) 1986-12-26 1986-12-26 頻尿治療剤

Publications (1)

Publication Number Publication Date
ZA879663B true ZA879663B (en) 1988-06-23

Family

ID=17984801

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879663A ZA879663B (en) 1986-12-26 1987-12-23 Propiophenone derivatives for treatmento of pollakiuria(frequency urination)

Country Status (10)

Country Link
US (1) US4912116A (fr)
EP (1) EP0273375B2 (fr)
JP (1) JPH0637389B2 (fr)
KR (1) KR920006907B1 (fr)
AT (1) ATE78685T1 (fr)
CA (1) CA1295251C (fr)
DE (1) DE3780787T2 (fr)
DK (1) DK685787A (fr)
HU (1) HU202752B (fr)
ZA (1) ZA879663B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1233715B (it) * 1989-07-14 1992-04-14 Menarini Farma Ind Uso in terapia della 10-ammino-5,6diidro-11h= dibenzo (b,e) azepina-6,11-dione e derivati, quali farmaci utili per il trattamento dell'incontinenza urinaria
ATE119890T1 (de) * 1989-08-04 1995-04-15 Mitsui Toatsu Chemicals Aminoketonderivate und ihre verwendung.
US5338857A (en) * 1989-08-04 1994-08-16 Mitsui Toatsu Chemicals Incorporated Aminoketone derivatives of 1,2-oxazole and use thereof
AT409083B (de) * 1999-04-01 2002-05-27 Sanochemia Pharmazeutika Ag Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
DE10341923A1 (de) * 2003-09-11 2005-04-07 Heinl, Alexander, Dr.med. Verwendung von Tolperison
AT500144A1 (de) * 2004-03-05 2005-11-15 Sanochemia Pharmazeutika Ag Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung
WO2006112565A1 (fr) * 2005-04-21 2006-10-26 Dreampharma Corp. Medicaments permettant de traiter la pollakiurie et l'incontinence urinaire, contenant un propiophenone presentant une activite optique et les sels de celui-ci
MX2008013437A (es) * 2006-04-20 2009-03-06 Sanochemia Pharmazeutika Ag Metodo para administrar tolperisona.
US8604031B2 (en) * 2006-05-18 2013-12-10 Mannkind Corporation Intracellular kinase inhibitors
ES2569660T3 (es) 2007-06-08 2016-05-12 Mannkind Corporation Inhibidores de la IRE-1alfa
WO2009038771A2 (fr) * 2007-09-19 2009-03-26 Massachusetts Institute Of Technology Tolpérisone et médicaments de type tolpérisone pour le traitement de cancers associés au k-ras

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139627A (en) * 1977-10-06 1979-02-13 Beecham Inc. Anesthetic lozenges
JPS5933276A (ja) * 1982-08-20 1984-02-23 Hokuriku Seiyaku Co Ltd 3−ピロリジノ置換プロピオフエノン誘導体
HU33131A (fr) * 1984-01-26 1984-10-29

Also Published As

Publication number Publication date
HUT45400A (en) 1988-07-28
DK685787A (da) 1988-06-27
KR920006907B1 (ko) 1992-08-22
KR880007462A (ko) 1988-08-27
EP0273375A3 (en) 1990-05-16
HU202752B (en) 1991-04-29
US4912116A (en) 1990-03-27
CA1295251C (fr) 1992-02-04
DE3780787T2 (de) 1995-08-24
EP0273375B2 (fr) 1995-05-10
DE3780787D1 (de) 1992-09-03
ATE78685T1 (de) 1992-08-15
DK685787D0 (da) 1987-12-23
EP0273375B1 (fr) 1992-07-29
JPH0637389B2 (ja) 1994-05-18
JPS63162621A (ja) 1988-07-06
EP0273375A2 (fr) 1988-07-06

Similar Documents

Publication Publication Date Title
EP0218999A3 (en) New quinazoline derivatives, process for their production and pharmaceutical compositions comprising them
PT87163A (pt) Process for preparing 1-phenyl-3-naphthalenyloxipropanamines
ZA879663B (en) Propiophenone derivatives for treatmento of pollakiuria(frequency urination)
HUT35238A (en) Process for producing diacyloxy-naphtalene derivatives of antipsoriatic activity and pharmaceutical compositions containing them as active agents
IE40068B1 (en) Isoquinoline derivatives and process for preparing them and phamaceutical preparations comprising them
DE3586649D1 (de) Verwendung von spergualinderivaten zur herstellung von arzneimitteln mit immunodepressiver wirkung.
ES8604960A1 (es) Procedimiento para preparar derivados de 1,6-naftiridina
DE69030502D1 (de) Cephalosporinverbindungen und deren herstellung
ATE102955T1 (de) Zyklisches tetrapeptid und verfahren zu dessen herstellung.
NO180487C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksadiazolylfenoksyalkylisoksazoler
PT900082E (pt) Utilizacao de piridilpiperazina e pirimidilpiperazina para o fabrico de um medicamento para o tratamento de perturbacoes de toxicomania
ATE122037T1 (de) Cyclohexanacetamid-derivate.
EP0123146A3 (en) Compounds with antiinflammatory activity, process for preparation thereof and pharmaceutical compositions therefrom
GB8608893D0 (en) D-nor-7-ergoline derivatives
ATE47389T1 (de) Kondensierte siebengliedrige heterozyklische verbindungen, ihre herstellung und verwendung.
HU893626D0 (en) New derivatives of leucotriene-b4, process for producing them and their application as medicament
IE40722B1 (en) Indolopiperdino-alkylthiazines
GB8610369D0 (en) Heterocyclic compounds
TH1764A (th) อิมิดาโซเบนโซไดอะซิบีน